S&P revises Boston Scientific outlook to negative on franchise pressures
Summary
Standard and Poor's has changed its rating outlook for Boston Scientific to negative. This adjustment reflects ongoing challenges within the company's business franchises. The credit agency will continue to monitor these operational pressures moving forward.
Source: Read the full story at Stock Market News
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.